VR Logo

ANI Pharmaceuticals Inc. (ANIP) download report


Healthcare | Drugs & Pharma

ANI Pharmaceuticals Inc. (ANIP) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.

IPO Date: 05-May-2000

Pres, CEO & Director: Mr. Nikhil Lalwani

CFO, Sr. VP of Fin. & Corp. Sec.: Mr. Stephen P. Carey

Listing: NASDAQ: ANIP

Country: United States

Headquarters: Baudette, MN

Website: https://www.anipharmaceuticals.com

Key Facts

Market cap: $601.02 Mln

Revenue (TTM): $125.41 Mln

Earnings (TTM): $-63.41 Mln

Cash: $76.91 Mln

Total Debt: $287.16 Mln

Insider's Holding: 13.20%

Liquidity: Low

52 Week range: $22.31 - 60.23

Shares outstanding: 17,236,000

10 Years Aggregate:

  • CFO: $206.71 Mln
  • EBITDA: $226.44 Mln
  • Net Profit: $-50.91 Mln

Stock Performance

Time Period ANI Pharmaceuticals (ANIP) S&P BSE Healthcare* S&P Small-Cap 600*
YTD-26.22-11.26-12.41
1 month8.115.347.33
3 months24.001.471.57
1 Year2.84-11.82-9.48
3 Years-22.7222.769.22
5 Years-4.7910.867.59
10 Years16.2212.2710.53
As on 09-Aug-2022 *As on 08-Aug-2022
Year ANI Pharmaceuticals (ANIP) S&P Small-Cap 600 S&P BSE Healthcare
202158.6825.2720.87
2020-52.919.5761.45
201936.9820.86-3.55
2018-30.01-9.70-5.89
20176.3211.730.49
201634.3424.74-12.88
2015-19.98-3.3615.06